Novocure Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
84.52 M |
Public Float |
- |
Novocure Ltd. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.6 |
Market Cap |
$6.16 B |
Shares Outstanding |
95.77 M |
Public Float |
73.07 M |
Address |
No. 4 The Forum St. Helier Jersey JE2 4UF United Kingdom |
Employees | - |
Website | http://www.novocure.com |
Updated | 07/08/2019 |
Novocure Ltd. operates as an oncology company. It enages in developing its propriety technoclogy, Tumor Treating Fields, which uses electric fields tuned to specific frequencies to disrupt cancer cell division, inhibiting tumor growth, and causing affected cancer cells to die. The company was founded by Yoram Palti in 2000 and is headquartered in St. |